Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/26591
Title: Long-term Improvement in Clinical Outcomes in Alemtuzumab-Treated RRMS Patients Who Relapsed Between Courses 1 and 2 (CARE-MS I)
Authors: Broadley, S.
Wiendl, Heinz
Fernandez, O.
Freedman, M. S.
Izquierdo, G.
Lycke, J.
Pozzilli, C.
Sharrack, B.
Singer, B. A.
Steingo, B.
Vermersch, P.
Wray, S.
VAN WIJMEERSCH, Bart 
Ziemssen, T.
Margolin, D. H.
Thangavelu, K.
Boster, A.
Issue Date: 2018
Source: MULTIPLE SCLEROSIS JOURNAL, 24(3), p. 399-399 (Art N° P-53)
Document URI: http://hdl.handle.net/1942/26591
ISSN: 1352-4585
e-ISSN: 1477-0970
DOI: 10.1177/1352458517751792
ISI #: 000429327000112
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
P-5.pdf
  Restricted Access		Published version63.99 kBAdobe PDFView/Open    Request a copy
Show full item record

Page view(s)

44
checked on Sep 7, 2022

Download(s)

32
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.